Research Article
Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir
Table 1
Characteristics of the studied population before treatment.
| Characteristics | Studied group (n = 87) |
| Qualitative variables (no., %) | Gender | | Male | 26 (29.9%) | Female | 61 (70.1%) |
| BMI | | 18.5–24.9 | 20 (23%) | 25.0–29.9 | 48 (55.2%) | 30.0 and above | 19 (21.8%) |
| Diabetes | | Yes | 6 (6.9%) | No | 81 (93.1%) |
| Hypertension | | Yes | 18 (20.7%) | No | 69 (79.3%) |
| Liver | | Normal | 60 (69%) | Cirrhotic | 27 (31%) |
| Quantitative variables (mean ± SD) | Age (years) | 50.18 ± 10.01 | HCV RNA (copies/ml) | 925507 ± 1241001 | Total bilirubin (mg/dl) | 0.88 ± 0.2 | Serum albumin (mg/dl) | 4.32 ± 0.52 | INR | 1.06 ± 0.08 | AST (U/L) | 44.66 ± 18.2 | ALT (U/L) | 49.2 ± 28.97 | HB (g/dl) | 13.48 ± 1.4 | Platelet (n × 103/μl) | 208.86 ± 66.02 | Creatinine (mg/dl) | 0.9 ± 0.48 | eGFR (ml/min per 1.73 m2) | 83.92 ± 20.18 | FIB4 score | 1.7 ± 0.9 | APRI score | 0.6 ± 0.39 |
|
|
BMI: body mass index; HCV RNA: hepatitis C virus-ribonucleic acid; INR: international normalization ratio; AST: aspartate aminotransferase; ALT: alanine aminotransferase; HB: hemoglobin; eGFR: estimated glomerular filtration rate; FIB4 : fibrosis four; APRI : AST to platelet ratio index.
|